1. Show article details.

    Baxter Publishes 2019 Corporate Responsibility Report, Highlighting Efforts to Make a Meaningful Difference as a Leading Global Corporate Citizen

    Business Wire – 9:00 AM ET 06/25/2020

    Progress toward corporate responsibility goals demonstrates continued value creation across environmental, social, economic and governance priorities Baxter International Inc. (BAX), a leading global medical products company, today released its 2019 Corporate Responsibility Report.

  2. Show article details.

    BRIEF-Baxter Highlights New Data On Improving Care For Dialysis Patients

    Reuters – 10:33 AM ET 06/10/2020

    Baxter International Inc (BAX): * BAXTER HIGHLIGHTS NEW DATA ON THE ROLE TECHNOLOGIES PLAY IN IMPROVING CARE FOR DIALYSIS PATIENTS DURING THE 57TH ERA-EDTA VIRTUAL CONGRESS. * BAXTER INTERNATIONAL (BAX) - USE OF CO'S SHARESOURCE REMOTE PATIENT MANAGEMENT PLATFORM WAS ASSOCIATED WITH A 56% REDUCTION IN TECHNIQUE FAILURE Source text for Eikon: Further company coverage:

  3. Show article details.

    Baxter Highlights New Data on the Role Technologies Play in Improving Care for Dialysis Patients During the 57th ERA-EDTA Virtual Congress

    Business Wire – 8:30 AM ET 06/10/2020

    DEERFIELD, Ill. “Given the COVID-19 pandemic, there has never been a more important time for patients to perform dialysis in the safety of their own homes, or to receive therapy they report is improving their quality of life,” said Laura Angelini, general manager, Baxter’s Renal Care business.

  4. Show article details.

    Wearable Devices Present an Economic Choice for Remote Patient Monitoring

    PR Newswire – 9:00 AM ET 06/03/2020

    NEW YORK, June 3, 2020 The wearable technology industry has undergone significant changes in the last decades. New wearable monitoring devices, equipped with the Internet of Things technology, are able to communicate with smartphones, transferring crucial data to user friendly applications.

  5. Show article details.

    Baxter to Present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast

    Business Wire – 4:15 PM ET 06/02/2020

    Baxter International Inc. (BAX), a leading global medical products company, will present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast on Tuesday, June 9, 2020. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through June 9, 2021.

  6. Show article details.

    Mexico orders probe into alleged graft linked to ex-president

    Reuters – 3:06 PM ET 05/20/2020

    Mexican President Andres Manuel Lopez Obrador on Wednesday ordered an investigation into allegations the former government irregularly awarded lucrative contracts to a firm reportedly owned by the family of his predecessor, Enrique Pena Nieto.

  7. Show article details.

    BRIEF-Baxter Receives CE Marking For EVO IQ Syringe Infusion System

    Reuters – 9:15 AM ET 05/20/2020

    Baxter International Inc (BAX): * BAXTER RECEIVES CE MARKING AND AUSTRALIAN REGULATORY APPROVAL FOR EVO IQ SYRINGE INFUSION SYSTEM, BUILDING ON SMART PUMP PLATFORM Source text for Eikon: Further company coverage:

  8. Show article details.

    Baxter Receives CE Marking and Australian Regulatory Approval for Evo IQ Syringe Infusion System, Building on Smart Pump Platform

    Business Wire – 9:00 AM ET 05/20/2020

    DEERFIELD, Ill. “Around the world, many clinicians prefer to have a choice between syringe and large volume infusion pumps to accommodate patient needs,” said David Ferguson, general manager of Baxter’s Medication Delivery business. The Evo IQ Syringe Infusion System can be used to deliver small volumes of medications and other fluids to patients in a controlled manner.

  9. Show article details.

    BRIEF-Baxter Announces Results Of Clinical Trial On Benefits Of Dynamic Fluid Management In Septic Shock Patients

    Reuters – 9:08 AM ET 05/06/2020

    Baxter International Inc (BAX): * BAXTER ANNOUNCES RESULTS OF CLINICAL TRIAL ON BENEFITS OF DYNAMIC FLUID MANAGEMENT IN SEPTIC SHOCK PATIENTS. * Baxter International Inc (BAX) - SAFETY ENDPOINTS WERE COMPARABLE BETWEEN INTERVENTION AND CONTROL ARMS IN STUDY Source text for Eikon: Further company coverage:

  10. Show article details.

    Baxter Announces Results of Clinical Trial on Benefits of Dynamic Fluid Management in Septic Shock Patients

    Business Wire – 9:00 AM ET 05/06/2020

    Results published in CHEST Journal demonstrate benefits of using dynamic measures to guide fluid therapy decisions Baxter International Inc. (BAX), a leader in innovative technology for medication delivery, today announced results of the Fluid Response Evaluation in Sepsis Hypotension and Shock study using the Starling Fluid Management Monitoring System, recently published in CHEST.

  11. Show article details.

    BRIEF-Baxter Increases Dividend And Declares Quarterly Dividend

    Reuters – 8:53 AM ET 05/05/2020

    Baxter International Inc (BAX): * BAXTER INCREASES DIVIDEND AND DECLARES QUARTERLY DIVIDEND. * SETS FY DIVIDEND OF $0.98PER SHARE. * ANNOUNCED AN INCREASE IN COMPANY'S QUARTERLY CASH DIVIDEND TO A RATE OF $0.245 PER SHARE OF COMMON STOCK.

  12. Show article details.

    Baxter Increases Dividend and Declares Quarterly Dividend

    Business Wire – 8:45 AM ET 05/05/2020

    Baxter International Inc. (BAX), a leading global medical products company, today announced an increase in the company’s quarterly cash dividend to a rate of $0.245 per share of common stock.

  13. Show article details.

    Sustainable ETF Tries an Active Approach -- Journal Report

    DJ Business News – 10:17 PM ET 05/03/2020

    Sustainable investing doesn't just benefit from an active approach-- it demands one. That's according to TrueMark Investments, which in early March launched TrueMark ESG Active Opportunities ETF. The exchange-traded fund aims to provide investors with access to large-cap U.S. companies that meet a set of environmental, social and governance standards, particularly in terms of carbon footprint.

  14. Show article details.

    BRIEF-Baxter Reports First-Quarter 2020 Results

    Reuters – 7:59 AM ET 04/30/2020

    Baxter International Inc (BAX): * BAXTER REPORTS FIRST-QUARTER 2020 RESULTS. * Q1 GAAP EARNINGS PER SHARE $0.64. * Q1 REVENUE $2.8 BILLION VERSUS REFINITIV IBES ESTIMATE OF $2.75 BILLION. * Q1 EARNINGS PER SHARE ESTIMATE $0.72 -- REFINITIV IBES DATA. * BAXTER INTERNATIONAL (BAX) - NOT IN POSITION TO PROVIDE GUIDANCE FOR Q2 OR FULL-YEAR 2020 AT THIS TIME.

  15. Show article details.

    Baxter Reports First-Quarter 2020 Results

    Business Wire – 7:15 AM ET 04/30/2020

    DEERFIELD, Ill. “Baxter’s medically essential portfolio puts us on the front lines of the COVID-19 pandemic, and our deepest gratitude goes to the healthcare providers and first responders battling the spread and impact of COVID-19.

  16. Show article details.

    Baxter to Present at the UBS Virtual Global Healthcare Conference

    Business Wire – 4:15 PM ET 04/27/2020

    Baxter International Inc. (BAX), a leading global medical products company, will present at the UBS Virtual Global Healthcare Conference on Tuesday, May 19, 2020 via webcast. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through November 15, 2020.

  17. Show article details.

    Baxter to Present at the Virtual BofA Securities 2020 Health Care Conference

    Business Wire – 4:15 PM ET 04/23/2020

    Baxter International Inc. (BAX), a leading global medical products company, will present at the virtual BofA Securities 2020 Health Care Conference via webcast on Tuesday, May 12, 2020. The live webcast of Baxter’s presentation can be accessed at www.baxter.com and will be available for replay through August 10, 2020.

  18. Show article details.

    Baxter Obtains U.S. FDA Emergency Use Authorization for Oxiris Blood Purification Filter for COVID-19 Treatment

    Business Wire – 2:30 PM ET 04/23/2020

    DEERFIELD, Ill. This press release features multimedia. “We are doing whatever it takes to support healthcare providers as they care for patients during extraordinary circumstances.

  19. Show article details.

    BRIEF-Baxter Says Audit Committee To Continue To Actively Oversee Remedial Actions

    Reuters – 7:10 AM ET 04/21/2020

    Baxter International Inc (BAX): * BAXTER - IN 2020, AUDIT COMMITTEE TO CONTINUE TO ACTIVELY OVERSEE REMEDIAL ACTIONS TO HELP ENSURE THAT EVENTS LEADING TO RESTATEMENT DO NOT RECUR. * BAXTER - BOARD DETERMINED TO FURTHER REDUCE CFO'S 2019 CASH BONUS BY $164,970 AND HIS 2020 EQUITY AWARD TARGET OPPORTUNITY BY 50% Source: Further company coverage:

  20. Show article details.

    Baxter to Host First-Quarter 2020 Financial Results Conference Call for Investors

    Business Wire – 4:15 PM ET 04/17/2020

    Baxter International Inc. (BAX), a leading global medical products company, will host a conference call to discuss its first-quarter 2020 financial results on Thursday, April 30, 2020, at 7:30 a.m. Central Time. To access the call, dial 886-1929 or 239-4663.

Page:

Today's and Upcoming Events

  • Jul
    30

    BAX to announce Q2 earnings (Confirmed)

Past Events (last 90 days)

  • Jun
    04

    BAX ex-Dividend for $0.25 on 06/04/2020

    • Announce Date: 05/05/2020
    • Record Date: 06/05/2020
    • Pay Date: 07/01/2020
  • Apr
    30

    BAX announced Q1 earnings.

Data provided by Thomson Reuters © 2020

Technical Events

Technical Analysis

PROVIDED BY TRADING CENTRAL
As with all your investments through Fidelity, you must make your own determination whether an investment is appropriate for you. Fidelity is not recommending or endorsing this security by making it available to customers. You should conduct research and perform a thorough investigation as to the characteristics of any securities you intend to purchase. Before investing, you should read the prospectus, offering circular, indenture, or similar document carefully for a full description of the product, including its features and risks, to determine whether it is an appropriate investment for your investment objectives, risk tolerance, financial situation and other individual factors, and be sure to re-evaluate those factors on a periodic basis.

Performance data shown represents past performance, which is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore, you may have a gain or loss when you sell your shares.


Stock markets are volatile and can decline significantly in response to adverse issuer, political, regulatory, market, or economic developments. Growth stocks can be more volatile than other types of stocks. Value stocks can continue to be undervalued by the market for long periods of time. Foreign securities are subject to interest-rate, currency-exchange-rate, economic, and political risks, all of which are magnified in emerging markets. Illiquidity is an inherent risk associated with investing in real estate and REITs. There is no guarantee the issuer of a REIT will maintain the secondary market for its shares and redemptions may be at a price which is more or less than the original price paid. Closed-end funds can trade at a discount to their NAV. Shareholders of Master Limited Partnerships may be treated as partners for tax purposes. Partnerships issue a Schedule K-1 (Form 1065) rather than a Form 1099 form for tax purposes. It lists the partner's share of income, deductions, credits, etc. Speak with your tax advisor to determine how this may affect you. A royalty trust is a type of corporation, mostly in the United States or Canada, usually involved in oil and gas production or mining. Royalty trusts may have special tax treatment, so you should consult a tax advisor on the potential tax consequences of investing in them.

News, commentary and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended for research purposes to help self-directed investors evaluate many types of securities including, but not limited to common stocks, American Depository Receipts, Master Limited Partnerships, real estate investment trusts. traditional preferred stock, trust preferred securities, third-party trust certificates, convertible securities, mandatory convertible securities and other exchange-traded equity and/or debt securities. Criteria and inputs entered, including the choice to make security comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from its use.

462499.6.0
See the Latest Features
Personalized
Get relevant information about your holdings right when you need it.
See Your Performance Click the portfolio icon to get information about stocks you own without leaving the research page.
Faster Access to Positions A shortcut to view the full list of positions in your portfolio? Yes, please! Use the ticker search box.
Add Your Own Notes Use Notebook to save your investment ideas in one convenient, private, and secure place.
Convenient For You
Research that's clear, accessible, and all in one place makes for a better experience.
One-Stop Shop See everything you need to make investment decisions right in the dashboard.
Access Anywhere No matter where you are, use the Stock Research experience across multiple devices.
New Ideas, On the Ready Find new ideas using quick links to the Stock Screener.
New Ways to Research
Discover new tools to add or diversify your existing research strategy.
StockTwits Read live tweets from the financial and investing community about the stock you're interested in.
Fundamental Analysis Save time on research by getting an overall assessment of a company's valuation, quality, growth stability, and financial health.
Recognia Technical Analysis Perfect for the technical trader—this indicator captures a stock's technical events and converts them into short, medium, and long-term sentiment.
Top Competitors See how a stock measures up by instantly comparing it to the industry average and its top four competitors.
Social Sentiment Get a sense of people's overall feelings towards a company in social media with this summary tool.
Earnings Data Monitor earnings expectations over the past three quarters and model a stock's price based on its P/E.